跳至主要内容
临床试验/EUCTR2015-002061-29-ES
EUCTR2015-002061-29-ES进行中(未招募)1 期

Prospective randomized clinical trial comparing the effect of vaginal misoprostol synchronously with supracervical ball, versus only vaginal misoprostol for induction of labor.

Consorci Sanitari de Terrassa0 个研究点开始时间: 2016年1月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Pegnant women with a term singleton pregnancy, cephalic presentation, reassuring fetal heart rate pattern, intact membranes and an unfavorable cervix (Bishop score less than 6), admitted to our institution for labour induction.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1- Exclusion criteria pre-randomization:
  • - Patient refusal to participate in the trial
  • - Misoprostol contraindication acording to the misoprostol leaflet:
  • - Severe Preeclampsia
  • - Prematurity (<37 weeks gestation dated by first trimester ultrasound)
  • - Previous cesarean section or previous uterine surgery
  • - Intrauterine growth restriction
  • - Whenever placement of supracervical balloon might lead to an increase in the risk of infections and chorioamnionitis:
  • - Premature rupture of membranes
  • - Maternal colonization with Streptococcus agalactiae at any time during the pregnancy
  • - Other infrequent situations that may act as a confounder factor:
  • - Multifetal gestation
  • - Breech presentation
  • - Stillbirth
  • 2- Exclusion criteria postrandomization
  • - Maternal leaving of the study during induction
  • - Adverse effects secondary to the supracervical balloon, such as pain or maternal discomfort

研究者

发起方
Consorci Sanitari de Terrassa

相似试验